Inventor
Mario Filion
Inventor
Longueuil, CA
Overview
Patents· 44 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07KPeptides15%
G01NInvestigating or analysing materials by determining their chemical or physical properties14%
C12NMicroorganisms or enzymes10%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
C07HSugars3%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology2%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
11,084,872Method for treating breast cancer202110,597,450Antibodies against kidney associated antigen 1 and antigen binding fragments thereof2020RE047672Methods of impairing osteoclast differentiation using antibodies that bind siglec-1520199,855,291'Anti-kidney associated antigen 1 (KAAG1) antibodies'20189,828,426Antibodies against kidney associated antigen 1 and antigen binding fragments thereof20179,822,170'Co-use of a clusterin inhibitor with an EGFR inhibitor to treat cancer'20179,695,419'Polynucleotides and polypeptide sequences involved in the process of bone remodeling'20179,617,337'Siglec-15 antibodies in treating bone loss-related disease'20179,512,211'Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume'20169,493,562'Anti-Siglec-15 antibodies'20169,393,302'Antibodies against kidney associated antigen 1 and antigen binding fragments thereof'20169,388,242'Nucleic acids encoding anti-Siglec-15 antibodies'20169,220,765'Bacterial ribonucleic acid cell wall compositions and methods of making and using them'20159,180,176'Bacterial ribonucleic acid cell wall compositions and methods of making and using them'20159,067,984'Methods of impairing osteoclast differentiation using antibodies that bind Siglec-15'20159,044,422'Bacterial ribonucleic acid cell wall compositions and methods of making and using them'20159,040,246'Methods of making antibodies that bind polypeptides involved in the process of bone remodeling'20158,937,163'Antibodies against kidney associated antigen 1 and antigen binding fragments thereof'20158,900,579'Siglec-15 antibodies in treating bone loss-related disease'20148,802,826'Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume'20148,741,289'Siglec 15 antibodies in treating bone loss-related disease'20148,580,257'Antibodies that specifically block the biological activity of kidney associated antigen 1 (KAAG1)'20138,540,988'Antibodies that bind polypeptides involved in the process of bone remodeling'20138,444,975'Method for inhibiting bone resorption'20138,431,126'Antibodies that bind polypeptides involved in the process of bone remodeling'20138,350,016'Oligonucleotide compositions and their use to induce apoptosis'20138,216,582'Polynucleotides and polypeptide sequences involved in cancer'20128,168,181'Methods of impairing osteoclast differentiation using antibodies that bind siglec-15'20127,989,160'Polynucleotides and polypeptide sequences involved in the process of bone remodeling'20117,947,436'Polynucleotides and polypeptide sequences involved in the process of bone remodeling'20117,893,242'Oligonucleotide compositions and their use to induce apoptosis'20117,662,792'Modulation of Fas and FasL expression'20107,635,686'Therapeutically useful triethyleneglycol cholesteryl oligonucleotides'20097,371,734'Oligonucleotide compositions and their use for the modulation of immune responses'20087,199,228'Oligonucleotide compositions and their use to induce apoptosis'20077,200,531'Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides'20077,157,436'Therapeutically useful synthetic oligonucleotides'20077,125,858'Hyaluronic acid in the treatment of cancer'20067,087,586'Oligonucleotide compositions and their use to induce differentiation of cells'20066,890,911'Method for the treatment of inflammation'20056,809,081'Chemotherapeutic composition and method'20046,794,368'Composition and method for inducing apoptosis in prostate cancer cells'20046,329,347'Composition and method for the treatment of bladder cancer'20016,326,357'Bacterial cell complex composition and method of use'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2013Patents assigned to BIONICHE LIFE SCIENCES INC (14)· patent assignee history
2001Based in Montreal, CA· patent location history
2004–2015Based in Laval, CA· patent location history
2011–2017Patents assigned to ALETHIA BIOTHERAPEUTICS INC (19)· patent assignee history
2011–2021Based in Longueuil, CA· patent location history
2012–2018Patents assigned to FILION MARIO (10)· patent assignee history
2012–2018Patents assigned to TREMBLAY GILLES BERNARD (10)· patent assignee history
2012–2013Patents assigned to SOOKNANAN ROY RABINDRANAUTH (5)· patent assignee history
2012Based in Quebec, CA· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALETHIA BIOTHERAPEUTICS INC | 19 | 2011–2017 |
| BIONICHE LIFE SCIENCES INC | 14 | 2001–2013 |
| FILION MARIOself | 10 | 2012–2018 |
| TREMBLAY GILLES BERNARD | 10 | 2012–2018 |
| SOOKNANAN ROY RABINDRANAUTH | 5 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Longueuil, CA | 25 | 2011–2021 |
| Laval, CA | 16 | 2004–2015 |
| Montreal, CA | 2 | 2001 |
| Quebec, CA | 1 | 2012 |